However, drugs directed at amyloid-β have failed to show clinical efficacy (Panza et al., 2018), leading researchers to focus more on the microtubule-associated protein tau (Congdon et al., 2018); the pathogenesis of AD is currently believed to be more closely correlated with tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.